APA (7th ed.) Citation

CUI, A., LI, J., JI, S., MA, F., WANG, G., XUE, Y., . . . LI, Y. (2020). 1833-P: A Novel Genetic Modified and Pegylated FGF21 Analog for the Treatment of Nonalcoholic Steatohepatitis in Nonhuman Primates. Diabetes, 69, N.PAG. https://doi.org/10.2337/db20-1833-P

Chicago Style (17th ed.) Citation

CUI, AOYUAN, JIAN LI, SHAOHUI JI, FENGGUANG MA, GENBEI WANG, YAQIAN XUE, ZHENGSHUAI LIU, XIAOHUI MA, and YU LI. "1833-P: A Novel Genetic Modified and Pegylated FGF21 Analog for the Treatment of Nonalcoholic Steatohepatitis in Nonhuman Primates." Diabetes 69 (2020): N.PAG. https://doi.org/10.2337/db20-1833-P.

MLA (9th ed.) Citation

CUI, AOYUAN, et al. "1833-P: A Novel Genetic Modified and Pegylated FGF21 Analog for the Treatment of Nonalcoholic Steatohepatitis in Nonhuman Primates." Diabetes, vol. 69, 2020, p. N.PAG, https://doi.org/10.2337/db20-1833-P.